Caring Brands (CABR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 May, 2026Executive summary
A special meeting of stockholders is scheduled for July 9, 2026, to vote on key proposals affecting capital structure and compliance with Nasdaq rules.
Proposals include approving additional investment rights, authorizing share issuance above 19.99% of outstanding stock, increasing authorized common shares, and potential adjournment to solicit more proxies.
The Board unanimously recommends voting in favor of all proposals.
Forward-looking statements address potential dilution, market impacts, and strategic flexibility for future growth.
Voting matters and shareholder proposals
Proposal 1: Approve additional investment rights for purchasers to buy more Series A Convertible Preferred Stock and warrants.
Proposal 2: Authorize issuance of common stock upon conversion of Series A Preferred Stock and exercise of warrants, potentially exceeding 19.99% of outstanding shares.
Proposal 3: Amend Articles of Incorporation to increase authorized common shares from 100 million to 500 million.
Proposal 4: Approve adjournment of the meeting if more time is needed to solicit proxies.
All proposals require a majority of votes cast for approval; abstentions and broker non-votes do not count as votes cast.
Board of directors and corporate governance
The Board is responsible for soliciting proxies and recommends voting for all proposals.
No director or executive officer has a substantial interest in the proposals beyond that of other stockholders.
Latest events from Caring Brands
- Shareholders to vote on major capital structure changes and new investment rights, with Board support.CABR
Proxy filing15 May 2026 - No revenue, higher losses, PIPE financing, share buybacks, and Nasdaq compliance risks in Q1 2026.CABR
Q1 202612 May 2026 - Early-stage wellness company faces significant losses and going concern risk amid market expansion.CABR
Registration filing6 May 2026 - 2025 saw minimal revenue, a $6.28M net loss, and major impairments despite a successful IPO.CABR
Q4 202531 Mar 2026 - IPO seeks $4M for wellness product growth amid losses and high market competition.CABR
Registration Filing7 Dec 2025 - IPO seeks $3.2M to fund wellness product launches amid high risk and competitive market.CABR
Registration Filing7 Dec 2025 - Raising $3.2M in IPO to fund wellness product launches amid ongoing losses and high risk.CABR
Registration Filing7 Dec 2025 - IPO seeks $3.2M for wellness product growth amid high risk and ongoing losses.CABR
Registration Filing7 Dec 2025